JAK1 and acute lymphoblastic leukemia: In contrast, PTPN2 is likely a tumor suppressor in acute lymphoblastic leukemia (ALL) because it inhibits JAK1, which is oncogenic in ALL, though PTPN2 levels are often low in ALL (80, 81).